In December 2024, the Ministry of Health presented the 2024–2028 Pharmaceutical Industry Strategy, a roadmap aiming to guarantee access to quality medicines, while promoting innovation and ensuring the sustainability of the health system. The Strategy has been drawn up by the ministries of Health, Finance, Industry and Tourism, and Science, Innovation and Universities, together with the main pharmaceutical industry associations.
The Strategy includes three axes developed through 21 actions encompassing:
- equitable access to medicines, covering unmet needs and ensuring the NHS sustainability;
- research, development and innovation; and
- competitiveness of the sector and its contribution towards strategic national autonomy.
The Strategy will be implemented throughout an “Alliance for the Strategy”, a space that brings together an Inter-ministerial Committee, as well as public and private actors. It will be run by a joint government-industry committee.